Monday, November 16, 2026Every story links to its original source.

Genome News

Genomics news, traced to the source.

Reading

On This Day in Genomics

Genetic study supported three groups within inflammatory bowel disease

Inherited genetic differences supported dividing inflammatory bowel disease into three groups according to where inflammation occurred. The International Inflammatory Bowel Disease Genetics Consortium study, published in Lancet on 18 October 2015, included 29,838 patients in its primary analysis. Its findings supported distinguishing Crohn's disease affecting the ileum, the final part of the small intestine, from Crohn's disease affecting the colon and from ulcerative colitis, rather than using the usual two diagnoses.

Patients came from 49 centres in 16 countries in Europe, North America and Australasia. Researchers tested links between 156,154 genetic variants and disease features described using the Montreal classification system, a standard framework for classifying inflammatory bowel disease. They combined known genetic associations into risk scores summarising a person's inherited susceptibility to particular disease features.

Three regions of the genome, NOD2, MHC, and MST1 3p21, were associated mainly with where disease occurred. Location stayed largely fixed during a median follow-up of 10·5 years, while disease behaviour changed substantially. After researchers accounted for location and age at onset, little or no genetic association with disease behaviour remained.

The combined genetic risk score was strongly associated with disease subtype (p=1·65 × 10(-78)), including after the three regions were excluded (p=9·23 × 10(-18)). Models using the score strongly distinguished Crohn's disease affecting the colon from disease affecting the ileum. The score also identified a small number of patients whose genetic profiles differed from their clinical diagnoses. These patients were more likely to have their diagnoses revised after follow-up (p=6·8 × 10(-4)).

The authors interpreted the findings as evidence for a continuum of disorders better explained by three groups than by the existing two diagnoses. They described disease location as an intrinsic feature, partly determined by genetics, and the major driver of changes in disease behaviour over time.

Sources

Back to today in history · Browse the archive